AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer

Hormonal carcinogenesis

Henderson, B. E., & Feigelson, H. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.427 · Cited by 821 · see citing works

Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo–keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones

PENNING, T. M., BURCZYNSKI, M. E., JEZ, J. M., HUNG, C.-F., LIN, H.-K., MA, H., MOORE, M., PALACKAL, N., & RATNAM, K. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510067 · Cited by 649 · see citing works

Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones

PENNING, T. M., BURCZYNSKI, M. E., JEZ, J. M., HUNG, C.-F., LIN, H.-K., MA, H., MOORE, M., PALACKAL, N., & RATNAM, K. (2000) · Biochemical Journal · doi:10.1042/bj3510067 · Cited by 649 · see citing works

Estrogen receptor (ER) β, a modulator of ERα in the uterus

Weihua, Z., Saji, S., Mäkinen, S., Cheng, G., Jensen, E. V., Warner, M., & Gustafsson, J.-Å. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.5936 · Cited by 507 · see citing works

Estrogen Receptor (ER)-β Reduces ERα-Regulated Gene Transcription, Supporting a “Ying Yang” Relationship between ERα and ERβ in Mice

Lindberg, M. K., Movérare, S., Skrtic, S., Gao, H., Dahlman‐Wright, K., Gustafsson, J.-Α., & Ohlsson, C. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0206 · Cited by 479 · see citing works

Molecular Endocrinology of Hydroxysteroid Dehydrogenases

Penning, T. M. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0302 · Cited by 436 · see citing works

Loss of ERβ expression as a common step in estrogen-dependent tumor progression

Bardin, A., Boulle, N., Lazennec, G., Vignon, F., & Pujol, P. (2004) · Endocrine Related Cancer · doi:10.1677/erc.1.00800 · Cited by 417 · see citing works

The role of 17 beta-hydroxysteroid dehydrogenases

Mindnich, R., Möller, G., & Adamski, J. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.12.006 · Cited by 354 · see citing works

17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes

Peltoketo, H., Luu-The, V, Simard, J., & Adamski, J. (1999) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0230001 · Cited by 302 · see citing works

Colocalization of Progesterone Receptors A and B by Dual Immunofluorescent Histochemistry in Human Endometrium during the Menstrual Cycle1

Mote, P. A., Balleine, R. L., McGowan, E. M., & Clarke, C. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5928 · Cited by 270 · see citing works

Human Cytosolic 3α-Hydroxysteroid Dehydrogenases of the Aldo-keto Reductase Superfamily Display Significant 3β-Hydroxysteroid Dehydrogenase Activity

Steckelbroeck, S., Jin, Y., Gopishetty, S., Oyesanmi, B., & Penning, T. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313308200 · Cited by 270 · see citing works

Role of Exogenous and Endogenous Hormones in Endometrial Cancer

AKHMEDKHANOV, A., Zeleniuch‐Jacquotte, A., & Toniolo, P. G. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03811.x · Cited by 269 · see citing works

Characteristics of a Highly Labile Human Type 5 17β-Hydroxysteroid Dehydrogenase1

Dufort, I., Rheault, P., Huang, X.-F., Soucy, P., & Luu-The, V. (1999) · Endocrinology · doi:10.1210/endo.140.2.6531 · Cited by 255 · see citing works

Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome

Kaku, T., Yoshikawa, H., Tsuda, H., et al. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00462-1 · Cited by 246 · see citing works

Estrogens in the causation of breast, endometrial and ovarian cancers — evidence and hypotheses from epidemiological findings

Persson, I. R. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00113-8 · Cited by 236 · see citing works

Molecular Endocrinology of Hydroxysteroid Dehydrogenases

Penning, T. M. (1997) · Endocrine Reviews · doi:10.1210/er.18.3.281 · Cited by 230 · see citing works

A guide to 17β-hydroxysteroid dehydrogenases

Adamski, J., & Jakob, F. J. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00383-x · Cited by 161 · see citing works

The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs.

Desmond, J. C., Mountford, J. C., Drayson, M. T., Walker, E. A., Hewison, M., Ride, J. P., Luong, Q. T., Hayden, R. E., Vanin, E. F., & Bunce, C. M. (2003) · PubMed · Cited by 150 · see citing works

Close kinship of human 20α-hydroxysteroid dehydrogenase gene with three aldo-keto reductase genes

Nishizawa, M., Nakajima, T., Yasuda, K., Kanzaki, H., Sasaguri, Y., Watanabe, K., & Ito, S. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00310.x · Cited by 149 · see citing works

Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer.

Sasaki, M., Dharia, A., Oh, B. R., Tanaka, Y., Fujimoto, S., & Dahiya, R. (2001) · PubMed · Cited by 147 · see citing works

Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action

Penning, T. M. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg022 · Cited by 137 · see citing works

Human type 3 3α-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells

Rižner, T. L., Lin, H. K., Peehl, D. M., Steckelbroeck, S., Bauman, D. R., & Penning, T. M. (2003) · Endocrinology · doi:10.1210/en.2002-0032 · Cited by 132 · see citing works

Characterization of a human 20alpha-hydroxysteroid dehydrogenase

Zhang, Y., Dufort, I., Rheault, P., & Luu-The, V. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250221 · Cited by 109 · see citing works

Current molecular aspects of the carcinogenesis of the uterine endometrium

Inoue, M. (2001) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.2001.01046.x · Cited by 90 · see citing works

Colocalization of Progesterone Receptors A and B by Dual Immunofluorescent Histochemistry in Human Endometrium during the Menstrual Cycle

Mote, P. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2963 · Cited by 89 · see citing works

Immunocytochemical Localization of Type 5 17 β-Hydroxysteroid Dehydrogenase in Human Reproductive Tissues

Pelletier, G., Luu-The, V., Tětu, B., & Labrie, F. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700602 · Cited by 88 · see citing works

Stromal PRs Mediate Induction of 17 -Hydroxysteroid Dehydrogenase Type 2 Expression in Human Endometrial Epithelium: A Paracrine Mechanism for Inactivation Of E2

Yang, S., Fang, Z., Gürateş, B., Tamura, M., Miller, J., Ferrer, K., & Bulun, S. E. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.12.0742 · Cited by 86 · see citing works

Hormones and Hormone Antagonists: Mechanisms of Action in Carcinogenesis of Endometrial and Breast Cancer

Flötotto, T., Djahansouzi, S., Gläser, M., Hanstein, B., Niederacher, D., Brumm, C., & Beckmann, M. W. (2001) · Hormone and Metabolic Research · doi:10.1055/s-2001-16936 · Cited by 70 · see citing works

The Analyses of 17β-Hydroxysteroid Dehydrogenase Isozymes in Human Endometrial Hyperplasia and Carcinoma¹

Utsunomiya, H., Suzuki, T., Kaneko, C., Takeyama, J., Nakamura, J., Kimura, K., Yoshihama, M., Harada, N., Ito, K., Konno, R., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7661 · Cited by 57 · see citing works

17-Beta-Hydroxysteroid Dehydrogenase in Human Breast and Endometrial Carcinoma

Sasano, H., Suzuki, T., Takeyama, J., Utsunomiya, H., Ito, K., Ariga, N., & Moriya, T. (2000) · Oncology · doi:10.1159/000055281 · Cited by 46 · see citing works

The correlation between the response to progestogen treatment and the expression of progesterone receptor B and 17β‐hydroxysteroid dehydrogenase type 2 in human endometrial carcinoma

Utsunomiya, H., Suzuki, T., Ito, K., Moriya, T., Konno, R., Sato, S., Yaegashi, N., Okamura, K., & Sasano, H. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01766.x · Cited by 44 · see citing works

Expression of 20.ALPHA.-Hydroxysteroid Dehydrogenase mRNA in Human Endometrium and Decidua.

Nakajima, T., Yasuda, K., Nishizawa, M., Okada, H., Yoshimura, T., Ito, S., & Kanzaki, H. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.105 · Cited by 18 · see citing works

Differential expression of 17beta-hydroxysteroid dehydrogenases types 2 and 4 in human endometrial epithelial cell lines

Husen, B., Psonka, N., Jacob-Meisel, M., Keil, C., & Rune, G. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0240135 · Cited by 16 · see citing works

Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review

Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450 · see citing works

Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism

Rižner, T. L., & Penning, T. M. (2014) · Steroids · doi:10.1016/j.steroids.2013.10.012 · Cited by 217 · see citing works

Steroid hormone transforming aldo–keto reductases and cancer

Penning, T. M., & Byrns, M. C. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.03700.x · Cited by 181 · see citing works

Structural and functional biology of aldo-keto reductase steroid transforming enzymes

Penning, T. M., Wangtrakuldee, P., & Auchus, R. J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00089 · Cited by 164 · see citing works

An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies

Byrns, M. C., Steckelbroeck, S., & Penning, T. M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.09.008 · Cited by 145 · see citing works

Androgens and endometrium: new insights and new targets

Simitsidellis, I., Saunders, P. T. K., & Gibson, D. A. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.022 · Cited by 107 · see citing works

Evidence of androgen action in endometrial and ovarian cancers

Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0551 · Cited by 73 · see citing works

Aldo–keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis

Hevir, N., Vouk, K., Šinkovec, J., Ribič-Pucelj, M., & Lanišnik Rižner, T. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.01.003 · Cited by 48 · see citing works

Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3

Beranič, N., Gobec, S., & Rižner, T. L. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.12.012 · Cited by 39 · see citing works

The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer

Sinreih, M., Knific, T., Anko, M., Hevir, N., Vouk, K., Jerin, A., Frković Grazio, S., & Rižner, T. L. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00368 · Cited by 33 · see citing works

Expression of human aldo–keto reductase 1C2 in cell lines of peritoneal endometriosis: potential implications in metabolism of progesterone and dydrogesterone and inhibition by progestins

Beranič, N., Brožič, P., Brus, B., Sosič, I., Gobec, S., & Rižner, T. L. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.12.011 · Cited by 16 · see citing works

Exogenous Glucocorticoids and a High-Fat Diet Cause Severe Hyperglycemia and Hyperinsulinemia and Limit Islet Glucose Responsiveness in Young Male Sprague-Dawley Rats

Beaudry, J. L., D'souza, A. M., Teich, T., Tsushima, R. G., & Riddell, M. C. (2013) · Endocrinology · doi:10.1210/en.2012-2114 · Cited by 44 · see citing works

The Effect of Fasting on Tissue Cyclic cAMP and Plasma Glucagon in the Obese Hyperglycemic Mouse

VINE, R. L. L., Voyles, N. R., Perrino, P. V., & Recant, L. (1975) · Endocrinology · doi:10.1210/endo-97-3-615 · Cited by 38 · see citing works

Modulation of Adipoinsular Axis in Prediabetic Zucker Diabetic Fatty Rats by Diazoxide

Alemzadeh, R., & Tushaus, K. (2004) · Endocrinology · doi:10.1210/en.2003-1523 · Cited by 38 · see citing works

The Paraventricular Nucleus of the Hypothalamus Has a Major Role in Thyroid Hormone Feedback Regulation of Thyrotropin Synthesis and Secretion

Taylor, T., Wondisford, F. E., Blaine, T. A., & Weintraub, B. D. (1990) · Endocrinology · doi:10.1210/endo-126-1-317 · Cited by 54 · see citing works

Growth hormone binding protein in the rat: effects of gonadal steroids

Carmignac, D. F., Gabrielsson, B. G., & Robinson, I. C. A. F. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243263 · Cited by 68 · see citing works